Price, Cost, Spend: Following Pfizer’s Rabbit

Fifteen years ago, I walked out in protest when a pair of Big Pharma recruiters visited my Community Health Sciences lecture at UCLA. Here we were, examining social determinants of health and assessing public health programs’ impact, and these folks were hawking their slick, updated employee gym and company swag? I didn’t stick around to […]

Six Questions For Clients About Patient Costs

I’ve had a few “getting to know you/maybe we should work together” calls this past month. (BTW, #grateful) And two potential clients asked me what % I would estimate for pass-through for their respective copay programs. I asked what they were thinking, ballpark, for wholesale acquisition cost (WAC). One flat out balked at sharing (which […]